£109k
−65%vs Dec 2024Active07136436Private limited companyCambridge
CAMBIVAC LTD
Significant control: Grant Craig Austin (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Cambivac Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
CAMBIVAC LTD is an active private limited company (company number 07136436) incorporated on 26 January 2010, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £109k and cash of £9,868, with 4 employees on average. Net assets fell 65% on the prior period (£310k). Across the last 3 periods on record the net-asset trend is falling.
Peer position · net assets
By net assets it sits in the upper half of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
02
Ownership and control
- Mr Grant Craig Austin
- owns 50–75% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Dr Albert Philip Adrian Mockett
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 26 January 201016 yrs ago
- Next accounts due
- 30 September 2027in 342 days
- Confirmation statement due
- 9 February 2027in 109 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£9,868
−95%vs Dec 2024Not reported
4
No changevs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £109k | £9,868 | £133k | — | — | −£201k | 4 |
| 31 December 2024 | £310k | £180k | £145k | — | — | — | 4 |
| 31 December 2023 | £564k | £391k | £185k | — | — | — | 4 |
Cash per employee£2,467Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £108,979 at 31 December 2025
- Net assets down 25% or more on the prior period-64.9% vs prior period
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 26 January 2010
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 342 days
- Confirmation statement duein 109 days
- Accounts period endNet assets £109k · small accounts
- Accounts period endNet assets £310k · small accounts
- Accounts period endNet assets £564k · small accounts
- Incorporated
08
Similar companies in Cambridge
- CELL GUIDANCE SYSTEMS LIMITEDCambridge · inc. Jan 2010
- X-BIOCELL LTDCambridge · inc. Mar 2010
- CAMBRIDGE NANOMATERIALS TECHNOLOGY LTDCambridge · inc. Oct 2009
- ONCOLYTIKA LTDEly · inc. Jul 2010
- MOLSCAPE RESEARCH LTDCambridge · inc. Sept 2010
- LYCOTEC LIMITEDCambridge · inc. Oct 2010
All companies incorporated on 26 January 2010 · in Jan 2010.
09
Reminders for CAMBIVAC LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.